Cella, D., Cappelleri, J. C., Bushmakin, A., Charbonneau, C., Li, J. Z., Kim, S. T., . . . Motzer, R. J. (2009). Quality of Life Predicts Progression-Free Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib Versus Interferon Alfa. American Society of Clinical Oncology.

Cella, David, Joseph C. Cappelleri, Andrew Bushmakin, Claudie Charbonneau, Jim Z. Li, Sindy T. Kim, Isan Chen, M. Dror Michaelson, και Robert J. Motzer. Quality of Life Predicts Progression-Free Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib Versus Interferon Alfa. American Society of Clinical Oncology, 2009.

Cella, David, et al. Quality of Life Predicts Progression-Free Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib Versus Interferon Alfa. American Society of Clinical Oncology, 2009.